A new report suggests that paying for cancer drugs based on how well they work in practice could help patients get new treatments faster.Original Article
You may also like
About the author
David Miller
a pharmacist, a tech enthusiastic, who explored the Internet to gather all latest information pharma, biotech, healthcare and other related industries.